WebNov 11, 2024 · Results: The two CAD with revascularization populations treated either with class III AAD and flecainide therapy were similar for age (74.9±9.2 vs 75.5±8.1), male gender (75% versus 70%), hypertension … WebFlecainide is an antiarrhythmic medication. It treats paroxysmal supraventricular tachycardia (PSVT), a potentially life-threatening irregular heartbeat. The prescription drug can slow or block electrical signals in the heart and stabilize the heartbeat. People taking flecainide should be monitored closely for problems with the heart, liver and ...
Flecainide: Package Insert - Drugs.com
WebPropafenone and flecainide have the slowest dissociation kinetics of the sodium channel blocking drugs and therefore have more bound drug and produce a greater degree of conduction slowing at rapid heart rates (use … WebJul 7, 2024 · Flecainide’s decreased use and reported poor tolerability may have stemmed from the CAST trial which was stopped early due to an increased risk of death due to … general thomas mifflin
Flecainide - StatPearls - NCBI Bookshelf
WebConclusions: Flecainide in select patients with stable CAD for AF has a favorable safety profile compared to class-3 AADs. These data suggest the need for prospective trials of … WebMar 1, 2024 · Flecainide may cause some people to become dizzy, lightheaded, or less alert than they are normally. Make sure you know how you react to this medicine before you drive, use machines, or do anything else that could be dangerous if you are dizzy or are not alert. If you have been using this medicine regularly for several weeks, do not suddenly ... WebFlecainide in select patients with stable CAD for AF has a favorable safety profile compared to class-3 AADs. These data suggest the need for prospective trials of flecainide in AF patients with CAD to determine if the current guideline-recommended exclusion is … general thomas metz